DNA Repair Inhibitor & Irradiation on Melanoma
NCT01469455
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Local Metastatic Melanoma
Interventions
DRUG:
DT01
Sponsor
DNA Therapeutics